Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report

Iwona Rospond-Kubiak; Wojciech Adamski; Kinga Sosnowska; Jarosław Kocięcki; Andrzej Marszałek

doi:10.5114/jcb.2018.75603

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

2/2018
vol. 10

Send email

Copy url:

abstract:

Case report

Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report

Iwona Rospond-Kubiak

,

Wojciech Adamski

,

Kinga Sosnowska

,

Jarosław Kocięcki

,

Andrzej Marszałek

J Contemp Brachytherapy 2018; 10, 2: 174–177

DOI: https://doi.org/10.5114/jcb.2018.75603

Online publish date: 2018/04/30

View full text Get citation

The aim of this study is to report the use of ruthenium brachytherapy as an adjunctive treatment in the management of an intraocular extension of the conjunctival squamous cell carcinoma (SCC).

In 2013, a 73-year-old man presented with a tumor blocking the angle and infiltrating corneal endothelium. The patient was treated with iridectomy, and after one month, ruthenium brachytherapy was applied. 4.5 years post-irradiation, the treated eye is painless, and no recurrence was noted.

We advocate the use of ruthenium brachytherapy as an eye salvage treatment with an intraocular extension of conjunctival SCC.

keywords:

Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report

Iwona Rospond-Kubiak , Wojciech Adamski , Kinga Sosnowska , Jarosław Kocięcki , Andrzej Marszałek

conjunctiva, eye, ruthenium, squamous cell carcinoma, tumor

Iwona Rospond-Kubiak

,

Wojciech Adamski

,

Kinga Sosnowska

,

Jarosław Kocięcki

,

Andrzej Marszałek